Daiichi Sankyo and GSK to Establish Vaccines Joint Venture in Japan
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 3 (Table of Contents)
Published: 14 Mar-2012
DOI: 10.3833/pdr.v2012.i3.1699 ISSN: 1756-7874
Section: Joint Venture
Fulltext:
Abstract
Daiichi Sankyo and GlaxoSmithKline have agreed to form a 50-50 joint venture for the development and distribution of vaccines in Japan...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS